A61K 2039/868
Kidney
Official title: {kidney}
A61K2039/868 (Kidney) appears on 35 US grants and 79 published applications in this corpus.
Search patents in A61K- Granted patents
- 35
- Published applications
- 79
- Assignees
- 36
- Inventors
- 137
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
| 2010 | 0 | 2 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 1 |
| 2016 | 2 | 3 |
| 2017 | 0 | 1 |
| 2018 | 1 | 1 |
| 2019 | 1 | 9 |
| 2020 | 0 | 6 |
| 2021 | 2 | 13 |
| 2022 | 4 | 11 |
| 2023 | 7 | 9 |
| 2024 | 6 | 15 |
| 2025 | 9 | 5 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Intracellular delivery of biomolecules to modify immune response8 Sep 2026US 12,728,163 B2Stemcell Technologies Canada Inc.
- Peptides displayed by HLA for use in immunotherapy against different types of cancers3 Jun 2025US 12,318,407 B2Immatics Biotechnologies GmbH
- T-cells expressing anti-LIV1 chimeric antigen receptor20 May 2025US 12,304,968 B2Crispr Therapeutics AG
- Peptides displayed by HLA for use in immunotherapy against different types of cancers6 May 2025US 12,290,530 B2Immatics Biotechnologies GmbH
- Peptides displayed by HLA for use immunotherapy against different types of cancers29 Apr 2025US 12,285,443 B2Immatics Biotechnologies GmbH
- Personalized cancer vaccines7 May 2026US 2026/0124285 A1ModernaTX, Inc.
- Neoantigen vaccines for cancer prevention30 Oct 2025US 2025/0332237 A1The Johns Hopkins University
- Methods and compositions for treating cancer14 Aug 2025US 2025/0257320 A1Crispr Therapeutics AG
- Cancer therapy with live attenuated bacteria27 Feb 2025US 2025/0064866 A1Prokarium Limited
- Viral vector constructs for delivery of nucleic acids encoding cytokines and uses thereof for treating cancer20 Feb 2025US 2025/0059564 A1Kriya Therapeutics, Inc.
Most cited
By later US patents
- Immunogenic WT-1 peptides and methods of use thereof16US 9,265,816 B2Sloan-Kettering Institute for Cancer Research · 2016
- Kidney specific tumor vaccine directed against kidney tumor antigen G-25015US 8,741,306 B2The Regents of the University of California · 2014
- Kidney-specific tumor vaccine directed against kidney tumor antigen G-25014US 7,572,891 B2The Regents of the University of California · 2009
- Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers7US 10,400,011 B2Immatics Biotechnologies GmbH · 2019
- Methods and compositions for treating cancer5US 11,254,912 B2Crispr Therapeutics AG · 2022